CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
methadone contingency +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01416584
NCT01416584N/ACompleted

A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment

Johns Hopkins University·interventional·Posted Aug 15, 2011·Updated Dec 5, 2017

In Brief

A clinical study evaluating methadone contingency and Methadone & Abstinence Contingency for Opiate Dependence. Completed, enrolled 98 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 15, 2011
Enrollment StartOct 1, 2008
Primary CompletionOct 1, 2013
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 14.9 years ago

Interventions

methadone contingencybehavioral

Participants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace.

Methadone & Abstinence Contingencybehavioral

Participants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace and they had to provide opiate and cocaine negative urine samples to maintain the maximum pay.